top of page
INTERAGENCY PAIN
RESEARCH COORDINATING
COMMITTEE
2011 National Prevention Strategy
This strategy was developed from the guidance from the public and the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health, the National Prevention and is a critical component of the Affordable Care Act. Designed to move American medical care from a system of sick care to one based on wellness and prevention.
Pain in the Nation
The Well Being Trust provided a grant to have this report written that discusses drug/alcohol/suicide and their collective impact on our nation.
2011 Public Health Action Plan to Integrate Mental Health Promotion and Mental Illness Prevention with Chronic Disease Prevention (CDC)
A strategy to prevent death and disability from chronic disease and to promote healthy behaviors by integrating mental health with public health programs that address chronic disease.
2011 Relieving Pain in America
Section 4305 of the 2010 Patient Protection and Affordable Care Act required the Secretary, Department of Health and Human Services (HHS), to enter into an agreement with the IOM for activities “to increase the recognition of pain as a significant public health problem in the United States.”
This report responds to the committee’s charge by providing a blueprint for transforming the way pain is understood, assessed, treated, and prevented. It provides recommendations for improving the care of people who experience pain, the training of clinicians who treat them, and the collection of data on pain in the United States.
2016 National Pain Strategy
The NPS recommendations; increase the precision of information about chronic
pain prevalence overall, for specific types of pain, and in specific population groups and to track changes in pain prevalence, impact, treatment over time, to enable evaluation of population-level interventions and identification of emerging needs. It also recommends development of the capacity to gather information electronically about pain treatments, their usage, costs, effectiveness, and safety.
2022 National Healthcare Quality and Disparities Report
AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) has provides an annual summary of the status of health and healthcare delivery in the United States since 2003.
2022 National Healthcare Quality and Disparities Report (powerpoint version)
AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) has provided an annual summary of the status of health and healthcare delivery in the United States since 2003.
Advisory Group - Healthcare.gov
This Council and Strategy represent an unprecedented opportunity. By emphasizing integration across federal departments, the Council creates the possibility for a Health-in-All possibilities approach to health, embracing a robust population health framework. The Advisory Group is chaired by Jeff Levi, CEO of the Trust for America’s Health (TFAH). He and TFAH are engaged in promoting this public health agenda in health reform and other federal budget efforts.
AHRQ Six Building Blocks - A Team Based Approach to Improving Opioid Management in Primary Care
AHRQ funded the Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care (6BBs or Building Blocks) program.
Developing a National Strategy - Healthcare.gov
These priorities will align with the prevention and wellness goals set out in the government’s Healthy People 2020 initiative, which sets health targets for the population over the next decade.
For the Public's Health/Revitalizing Law and Policy to Meet New Challenges
This committee, convened at the IOM at the request of the Robert Wood Johnson Foundation to review population health strategies, associated metrics, and interventions in the context of a reformed health care system.
For the Public's Health/Revitalizing Law and Policy to Meet New Challenges - For the Public's Health
Summary of the committee's findings
Guidance for the National Healthcare Disparities Report
AHRQ commissioned the IOM to provide guidance on technical aspects of the report, including the measurement of disparities in health care access, quality, and service utilization; the measurement of socioeconomic status and geographic disparities; and the use of subnational datasets to support disparity measurement.
Health in All Policies Guide
This guide reflects a variety of approaches to Health in All Policies, and provides local, state, and national case examples from across the United States and around the world, it draws heavily on the authors’ experiences in California and from documents produced by the California Health in All Policies Task Force.
Health Literacy in Action Plan - Summary
The summary plan to attain the goal of improving health literacy—is critical to achieving the objectives set forth in Healthy People 2020 and, more broadly, key to the success of our national health agenda.
Healthier US/Executive Summary
President Bush's HealthierUS Initiative is based on the premise that increasing personal fitness and becoming healthier is critical to achieving a better and longer life. This initiative uses the resources of the Federal Government to alert Americans to the vital health benefits of simple and modest improvements in physical activity, nutrition, and behavior.
HHS Multiple Chronic Conditions/A Strategic Framework
This framework contains a vision statement, goals, objectives, and discrete strategies to guide the department in coordinating its efforts internally and collaborating with stakeholders externally. The intention for this framework is to catalyze change within the context of how chronic illnesses are addressed in the United States—from an approach focused on individual chronic diseases to one that uses a multiple chronic conditions approach. It is this culture change/paradigm shift, and the subsequent implementation of these strategies that will provide a foundation for realizing the vision of optimum health and quality of life for individuals with multiple chronic conditions.
Leveraging A Learning Collaborative Model to Develop and Pilot Quality Measures to Improve Opioid Prescribing in the Emergency Department
The E-QUAL Opioid Initiative was launched in 2018 with the goal of supporting and implementing opioid analgesic best practices in ED's across the country. During the 2019 E- QUAL Opioid Collaborative, the primary structured QI project of participating EDs was focused on reducing the harms associated with opioid prescribing.
Managing Multiple Chronic Conditions/A Strategic Framework for Improving Health Outcomes and Quality of Life
Developed by the U.S. Department of Health and Human Services with input from stakeholder organizations— that outlines national strategies for maximizing care coordination for individuals with multiple chronic conditions. The framework’s potential can be optimized through some of the provisions of the new Patient Protection and Affordable Care Act, and through public-private partnerships.
Mental Health/A Report of the Surgeon General
The national prevention agenda can be informed by understanding how the strengths of different groups' cultural and historical experiences might be drawn upon to help prevent the emergence of mental health problems or reduce the effects of mental illness when it strikes. This Supplement takes a first step in this direction.
National Action Plan to Improve Health Literacy
The National Action Plan to Improve Health Literacy envisions a restructuring of the ways we create and disseminate all types of health information in this country. The degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions—is critical to achieving the objectives set forth in Healthy People 2020 and, more broadly, key to the success of our national health agenda.
National Prevention Strategy
The National Prevention Strategy will move us from a system of sick care to one based on wellness and prevention. It builds upon the state-of-the-art clinical services we have in this country and the progress that has been made toward understanding how to
improve the health of individuals, families, and communities through prevention.
National Stakeholder Strategy for Achieving Health Equity
The initial and primary product of the NPA (National Partnership for Action to End Health Disparities) the National Stakeholder Strategy for Achieving Health Equity (National Stakeholder Strategy) provides an overarching roadmap for eliminating health disparities through cooperative and strategic actions. The other two key components of the NPA include: Blueprints for Action that are aligned with the National Stakeholder Strategy and guide action at the local, state, and regional levels; and targeted initiatives that will be undertaken by partners across the public and private sectors in support of the NPA.
National Drug Control - 2022
This inaugural Strategy proposes actions to lower overdose deaths in the
immediate term and reduce drug use and its damaging consequences over the longer term. These actions are based on available science, evidence, and data. Through them, we strive to
usher in a new era of drug policy centered on individuals and communities.
This Strategy is the product of the Office of National Drug Control Policy in close collaboration with the 18 National Drug Control Agencies and sought the input of more than 2,000 leaders and stakeholders including the entirety of the Congress; all 50 Governors; and advocates representing public safety, public health, community groups, local governments, and Tribal communities.
NPP Input to HHS on Priorities for 2011 National Quality Strategy - Final Report
HHS contracted with the National Quality Forum (NQF) to convene the National
Priorities Partnership (NPP)—a multi-stakeholder group including organizations representing the interests of consumers, purchasers, healthcare providers and professionals, state-based
associations, community collaborative and regional alliances, government agencies, health plans, accreditation and certification bodies, and supplier and industry groups—to provide input on a proposed framework for the National Quality Strategy and recommendations for a set of national priorities and goals.
HHS’s proposed framework includes three pillars—better care, affordable care, and healthy people/healthy communities—that a set of national priorities and goals should address.
Additionally, HHS has identified four core principles to serve as a foundation
for the National Quality Strategy and that identified priorities and goals also should aim to improve: person-centeredness and family engagement; care for patients of all ages, populations, service locations, and sources of coverage; elimination of disparities in care; and
opportunities for the alignment of public and private sectors.
Prescription Drug Abuse Prevention Plan
This Prescription Drug Abuse Prevention Plan expands upon the Administration’s National Drug Control Strategy and includes action in four major areas to reduce prescription drug abuse: education, monitoring, proper disposal, and enforcement.
Prevention of Mental, Emotional and Behavior Disorders Among Young People/Progress and Possibilities
This report is the work of the Committee on the Prevention of Mental Disorders and Substance Abuse Among Children, Youth, and Young Adults: Research Advances and Promising Interventions, a project of the National Research Council (NRC) and the Institute of Medicine (IOM).
Prevention Through Design Plan for the National Initiative
The following document provides the rationale, mission, objectives, outcomes, and timeframe for the Prevention through Design (PtD) National Initiative.
Priority Areas for National Action - Transforming Health Care Quality
In the 2001 report Crossing the Quality Chasm: A New Health System for the 21st Century, the Institute of Medicine (IOM) called for fundamental change in a troubled and ailing health care system. The change requires substantial improvements in six major aims outlined in that report—that health care be safe, effective, patient- centered, timely, efficient, and equitable. The report further suggested that the Agency for Healthcare Research and Quality (AHRQ) identify not fewer than 15 priority conditions for the purpose of developing strategies, goals, and action plans for achieving substantial improvements in quality in the next 5 years for each of the priority conditions.
Report to Congress/National Strategy for Quality Improvement in Health Care
The Affordable Care Act seeks to increase access to high-quality, affordable health care for all Americans. To that end, the law requires the Secretary of the Department of Health and Human Services (HHS) to establish a National Strategy for Quality Improvement in Health Care (the National Quality Strategy) that sets priorities to guide this effort and includes a strategic plan for how to achieve it. This report describes the initial Strategy and plan for implementation.
Stakeholder Engagement/Healthcare.gov
description
The Guide to Clinical Preventative Services 2014
Recommendations for preventive care have evolved over time as it has become widely
recognized that some “preventive” services were not actually beneficial. Individual health care providers, professional organizations, integrated health systems, insurers (both private and public), as well as groups crafting health quality measures and national health objectives, have recognized the need to carefully balance potential benefits and harms using the highest quality of evidence, and have adopted the recommendations of the Task Force. The primary audience for the USPSTF’s work remains primary care clinicians, and the recommendations are now considered by many to provide definitive standards for preventive services. The work of the USPSTF is recognized by the Patient Protection and Affordable Care Act. Under the law, preventive services with a Task Force grade of A or B must be covered without cost-sharing (e.g., copayment or deductible) under new health insurance plans or policies.
The National Prevention Strategy Draft December 2010
The National Prevention Strategy will present a vision, goals, recommendations, and action items that public, private, nonprofit organizations, and individuals can meet to reduce preventable death, disease, and disability in the United States. Working closely with partners across the country in both the public and private sectors, the National Prevention, Health Promotion, and Public Health Council (National Prevention Council) will develop the National
Prevention Strategy. The seventeen federal departments and agencies that comprise the National Prevention Council bring diverse missions and assets from various sectors. To provide guidance to the National Prevention Council, the President will establish an Advisory Group on prevention, health promotion, and integrative and public health composed of not more than 25 nonfederal members.
The Surgeon General's Call to Action to Improve the Health and Wellness of Persons with Disabilities 2005
Today, 54 million Americans—more than one fifth of us—are living with at least one disability. Some individuals are born with a disability; others acquire disabilities over the course of their lifetime. At any time, each of us is at risk for acquiring a disability, whether through an illness, an injury, genetics, or any number of other causes. With the “baby boom” generation approaching later life, there will be increased numbers of persons with or at risk for a disability. The sheer numbers of persons with disabilities today and tomorrow mean that disability is an issue for the nation as a whole, not just for those of us concerned about public health.
Understanding Disparities in Persons with Multiple Chronic Conditions/Research Approaches and Datas
This white paper contributes to meeting the goals outlined by the HHS strategic framework by examining promising data, methods, and topics for future disparities research within the MCC population. It builds on a previous white paper titled “Understanding the High Prevalence of Low- Prevalence Chronic Disease Combinations: Databases and Methods for Research”, which describes the “long tail” of the MCC distribution: approximately one-third of all Medicare patients have one of the most common combinations of MCC, but another third of all patients have one of two million unique combinations of MCC and account for 79% of health care costs.
US Preventative Services Task Force Guides to Clinical Preventative Services
The U.S. Preventive Services Task Force is an independent panel of experts in primary care and prevention that systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services. Sponsored since 1998 by the Agency for Healthcare Research and Quality (AHRQ), the Task Force is the leading independent panel of private-sector experts in prevention and primary care.
HHS Action Plan to Reduce Racial and Ethnic Health Disparities
The HHS Disparities Action Plan complements the 2011 National Stakeholder Strategy for Achieving Health Equity, a product of the National Partnership for Action (“NPA Stakeholder Strategy”).
FDA STRATEGIES
FDA - TRACK
FDA’s Office of Global Policy and Strategy holds a unique role in helping to advance and safeguard Americans by way of ensuring global considerations are fully integrated into FDA’s policies and operational activities. In a uniform fashion, the Office of Global Policy and Strategy seeks to achieve this through the mutual reinforcement of policy coherence, the strengthening of global partnerships, and the collection, analysis, and disseminating of high-quality information. Within a similar fold, the Office of Global Policy and Strategy works to enhance the breadth of international policy and diplomacy as well as compliance efforts taking place on the front-lines, both domestically and aboard, in order to maintain regulatory symmetry while also mitigating issues as they arise. It’s the hope that with these objectives working in tandem together that our office is able to continue to protect and promote public health to the fullest extent possible. Explore the progress OGPS is making to protect public health below.
FDA - Globalization
In today's world, other countries produce significant portions of the food and medical products that U.S. consumers and patients use in their daily lives. In fact, 136,400 foreign facilities in more than 150 countries export FDA-regulated products to the United States. U.S. imports include:
Approximately 10 to 15 percent of the U.S. food supply;
53 percent of fresh fruits, 29 percent of vegetables, and 93 percent of seafood consumed in the U.S. and,
About 35 percent of the medical devices used in the U.S.
FDA faces ever-greater challenges in determining whether a product has been properly manufactured, distributed and stored and even in determining who has handled the product. The manufacture of a single product can now involve multiple parties from different countries that are engaged at various steps throughout the process. Along the way, there are opportunities for the product to be improperly formulated or packaged, contaminated, diverted, counterfeited or adulterated.
FDA has mobilized diverse approaches as part of its strategy to address the complex issues posed by globalization, including efforts to:
develop new enforcement and regulatory tools
conduct more foreign inspections
increase collaboration with foreign regulators and other stakeholders
develop internationally-harmonized standards and standards convergence
educate foreign industry about FDA requirements, and
increase transparency and accountability in the supply chain
Responsibility for addressing these global issues is distributed across the agency. The Office of Regulatory Affairs conducts inspections and reviews imported products offered for entry into the United States. FDA’s product centers focus on international policy and outreach that touches on their portfolio of regulated products and the Office of Global Policy and Strategy serves as a focal point for FDA-wide coordination and information sharing and a point of access to multilateral organizations like the World Health Organization; addresses issues related to international trade of regulated products and mutual recognition agreements; enters into arrangements that facilitate the sharing of information with global regulatory counterparts; and manages FDA’s foreign offices around the world.
FDA Patient Listening Sessions
FDA Patient Affairs hosts Patient Listening Sessions. These sessions are a resource for the medical product Centers to engage with patients and their advocates. Patient Listening Sessions are one of many ways the patient and advocacy community can share their experiences and perspectives by talking directly with FDA staff.
bottom of page